Clinical Trials on Relapsed or Refractory Solid Tumors in Australia
Total 692 results
-
CStone PharmaceuticalsCompleted
-
CStone PharmaceuticalsCompletedSolid Tumor, AdultAustralia
-
Shanghai Henlius BiotechCompletedAdvanced Solid TumorsAustralia
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A., GenevaCompletedCancer | Solid TumorsFrance, Belgium, Australia, Netherlands
-
LaNova Australia Pty LimitedRecruitingAdvanced Solid TumorAustralia
-
Curon Biopharmaceutical (Australia) Co Pty LtdNovotech (Australia) Pty LimitedTerminatedRelapsed Lymphoid Malignancies | Refractory Lymphoid MalignanciesAustralia
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Australia
-
Waterstone Hanxbio Pty LtdCompletedAdvanced Solid TumorAustralia
-
CStone PharmaceuticalsCompleted
-
Glycotope GmbHGlycotope Biotechnology GmbHCompleted
-
Impact Therapeutics, Inc.RecruitingSolid Tumor | Advanced Solid TumorChina, Taiwan, United States, Australia
-
Elpiscience Biopharma Australia Pty. Ltd.RecruitingAdvanced Solid TumorAustralia
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingLocally Advanced Solid TumorAustralia
-
Ludwig Institute for Cancer ResearchDaiichi Sankyo Co., Ltd.; Austin HealthCompletedMalignant Solid Tumor | Metastatic EphA2 Positive CancerAustralia
-
Antengene Biologics LimitedRecruitingAdvanced/Metastatic Solid TumorsChina, Australia
-
Eucure (Beijing) Biopharma Co., LtdRecruiting
-
BeiGeneActive, not recruiting
-
Neurogene Inc.Merck Sharp & Dohme LLCActive, not recruitingSolid Tumor | Advanced Solid TumorUnited States, Australia, Canada
-
BeiGeneSpringWorks Therapeutics, Inc.RecruitingSolid Tumor, AdultAustralia, United States
-
Hoffmann-La RocheTerminatedSolid TumorsSpain, Australia, Belgium, Denmark, Canada
-
National Cancer Institute (NCI)Children's Oncology GroupActive, not recruitingRefractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Histiocytic and Dendritic Cell Neoplasm | Recurrent Langerhans Cell Histiocytosis | Recurrent Lymphoma | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant... and other conditionsUnited States, Puerto Rico, Australia
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Australia
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid TumorsIsrael, United States, Australia
-
Inimmune CorporationAvance Clinical Pty Ltd.Not yet recruiting
-
Shanghai EpimAb Biotherapeutics Co., Ltd.RecruitingAdvanced Solid TumorAustralia, China
-
Atridia Pty Ltd.Active, not recruitingAdvanced Solid TumorAustralia
-
Hutchison Medipharma LimitedTerminated
-
BeiGeneCompletedFor Participants With Advanced Solid Tumors Failed With Previous Lines of TreatmentAustralia
-
Bio-Thera SolutionsTerminatedAdvanced Solid TumorAustralia
-
ModernaTX, Inc.AstraZenecaActive, not recruitingDose Escalation: Relapsed/Refractory Solid Tumor Malignancies or Lymphoma | Dose Expansion: Triple Negative Breast Cancer, HNSCC, Non-Hodgkins, Urothelial Cancer, Immune Checkpoint Refractory Melanoma, and NSCLC LymphomaUnited States, Israel, Australia
-
Bio-Thera SolutionsTerminatedAdvanced Solid TumourAustralia
-
CStone PharmaceuticalsTerminated
-
Servier Bio-Innovation LLCInstitut de Recherches Internationales ServierRecruitingMTAP-deleted Solid TumorsAustralia, United States
-
Hoffmann-La RocheTerminatedSolid TumorsBelgium, United States, Australia, Denmark, Spain, United Kingdom
-
AmgenCompletedAdvanced Solid TumorsBelgium, Canada, Australia, United States, Spain, Poland, France, Germany, Japan, United Kingdom
-
Bristol-Myers SquibbCompletedSolid TumorsUnited States, Australia, Spain, Germany, France, Switzerland, Netherlands, Canada, Belgium, Italy
-
Eucure (Beijing) Biopharma Co., LtdCompletedAdvanced Solid TumorAustralia
-
Stingray TherapeuticsRecruitingAdvanced / Metastatic Solid TumorAustralia
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
Medical University of ViennaUnknown
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Spain, Belgium, Denmark, Canada, Australia
-
Shanghai Best-Link Bioscience, LLCRecruitingAdvanced Solid TumorChina, Australia
-
Athenex, Inc.PharmaEssentia; Zenith Technology Corporation LimitedCompletedSolid TumorNew Zealand, Taiwan, Australia
-
AstraZenecaActive, not recruitingSolid TumorsBelgium, United Kingdom, Switzerland, Australia
-
Strand Therapeutics Inc.RecruitingAdvanced Solid TumorUnited States, Australia
-
ModernaTX, Inc.Merck Sharp & Dohme LLCRecruitingSolid TumorsUnited States, Australia
-
AstraZenecaCompletedAdvanced Solid TumoursKorea, Republic of, Australia, Japan
-
BeiGeneRecruitingAdvanced Solid TumorChina, United States, Australia, New Zealand, Korea, Republic of
-
PfizerCompletedSolid Tumor | Unspecified Adult Solid Tumor, Protocol SpecificUnited States, Australia, Canada, France, Spain
-
Activartis BiotechCompletedChildhood Solid TumorAustria